ASH Clinical News ACN_4.12_Full book Web | Page 7

VOLUME 04 | NUMBER 12 | OCTOBER 2018 Around the Network AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: [phone] IN THIS ISSUE pulling back the curtain Vip Viprakasit, MD, DPhil EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS Dr. Viprakasit talks about working in a limited-resource setting and his surprising talent for singing. Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH 15 demystifying the lab Epigenetics 101 ASSOCIATE EDITORS Beth Faiman, CNP, PhD Cleveland Clinic Cleveland, OH How does a cell’s “software” dictate when and how it becomes malignant? Alice Ma, MD 30 University of North Carolina School of Medicine Chapel Hill, NC David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ The Realities of Right to Try Experts weigh in on the “Right to Try” debate to find out more about the purpose of the legislation, how it differs from existing pathways to investigational drugs, and the pros and cons of increased access to investigational therapies. 32 clinical news 20 M  apping Silent Cerebral Infarcts in Children With Sickle Cell Anemia 26 D oes Carfilzomib’s Benefit Outweigh Its Risk for Cardiac Toxicity? PUBLISHER American Medical Communications (AMC) ASHCLINICALNEWS.ORG EDITORIAL MANAGING EDITORS Kristin Hubing, ASH Ariel Jones-DeMaio, AMC Want to hear more from the talented hematologists and oncologists we interview for our print issue? EDITORIAL ASSOCIATE Laurie Adamson, ASH Visit ashclinicalnews.org/sound-bites to hear everything we couldn’t fit in print! ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ADVERTISING ACCOUNT DIRECTORS Nick Luciano [email protected] Gene Conselyea [email protected] Sima Sherman [email protected] Recruitment advertising orders can be sent to: CLASSIFIEDS ACCOUNT MANAGER Lauren Morgan [email protected] Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews A | S | B | P| E Fostering B2B editorial excellence American Society of Business Publication Editors 2018 National PR INT Gold ©2018 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or oth- erwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. ASHClinicalNews.org Also, check out our daily updates from the world of hematology and health care in our “Online Exclusives,” with recent stories like: • First CRISPR Study Backed by U.S. Companies Launches • U.K. Says CAR-T Cell Therapy for Non-Hodgkin Lymphoma Is Too Expensive • NIH Investigating U.S. Research Institutions’ Foreign Ties @ASHCLINICALNEWS Make sure to follow us at @ASHClinicalNews for the latest updates in hematology! And don’t forget to sign up to receive our eNewsletters to have the latest updates from ASH Clinical News delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up. Visit ashclinicalnews.org/online-exclusives for more. “YOU MAKE THE CALL” WINNER Announcing last month’s “You Make the Call: Readers’ Response” winner: Fauzia Rana, MD, MBBS Hope you enjoy your prize! For your chance to win, be sure to send in your response to each month's You Make the Call question! Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published monthly by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. Periodicals postage paid at Freehold, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2018. ASH Clinical News 5